KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bristol Myers Squibb (BMY) FCF Payout Ratio (2016 - 2025)

Historic FCF Payout Ratio for Bristol Myers Squibb (BMY) over the last 17 years, with Q4 2025 value amounting to 0.79.

  • Bristol Myers Squibb's FCF Payout Ratio rose 16232.56% to 0.79 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.39, marking a year-over-year increase of 1260.25%. This contributed to the annual value of 0.39 for FY2025, which is 1260.25% up from last year.
  • According to the latest figures from Q4 2025, Bristol Myers Squibb's FCF Payout Ratio is 0.79, which was up 16232.56% from 0.21 recorded in Q3 2025.
  • In the past 5 years, Bristol Myers Squibb's FCF Payout Ratio ranged from a high of 0.79 in Q4 2025 and a low of 0.0 during Q2 2021
  • In the last 5 years, Bristol Myers Squibb's FCF Payout Ratio had a median value of 0.32 in 2021 and averaged 0.37.
  • In the last 5 years, Bristol Myers Squibb's FCF Payout Ratio crashed by 9880.08% in 2021 and then soared by 1208690.11% in 2023.
  • Quarter analysis of 5 years shows Bristol Myers Squibb's FCF Payout Ratio stood at 0.29 in 2021, then skyrocketed by 31.53% to 0.39 in 2022, then fell by 23.54% to 0.3 in 2023, then rose by 1.41% to 0.3 in 2024, then skyrocketed by 162.33% to 0.79 in 2025.
  • Its FCF Payout Ratio stands at 0.79 for Q4 2025, versus 0.21 for Q3 2025 and 0.35 for Q2 2025.